Gil D. Rabinovici
UCSF
Gil D. Rabinovici is listed as UCSF. Gil is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 19 March 2027.
Compiled from published conference agendas; not yet confirmed by Gil. Is this you? Claim this profile.
About
Dr. Rabinovici is the Edward and Pearl Fein Distinguished Professor in the UCSF Departments of Neurology, Radiology & Biomedical Imaging. He received his BS degree from Stanford University and MD from Northwestern University. He completed neurology residency and behavioral neurology fellowship at UCSF. Dr. Rabinovici’s work investigates how structural, functional and molecular brain imaging techniques can be used to improve diagnostic accuracy in dementia and to study the biology of neurodegenerative diseases, with the goal of accelerating drug development. He is Director of the UCSF ADRC, study chair of the IDEAS) and New IDEAS studies, co-PI of ALZNET, LEADS, CLARiTI and DIAGNOSE CTE -II, among other studies. His research is supported by NIH, Alzheimer’s Association, American College of Radiology, Rainwater Charitable Foundation, Weill Neurohub Alliance for Therapies in Neuroscience and additional foundations and industry partners. Previous awards include the 2025 Potamkin Prize
Upcoming
AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027
- PRECISION NEUROLOGY: MATCHING THE RIGHT DRUG TO THE RIGHT PATIENT—FROM BIOMARKERS TO CLINICAL REALITY Panellist · 19 March 2027
- ANTI-AMYLOID THERAPY: FROM TRIALS TO THE REAL WORLD Speaker · 20 March 2027